MedPath

COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

Phase 3
Completed
Conditions
Covid19
Interventions
Registration Number
NCT04650087
Lead Sponsor
Thomas L. Ortel
Brief Summary

A multicenter, adaptive, randomized platform trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge

Detailed Description

This study is an adaptive, prospective, randomized platform trial designed to compare the effectiveness and safety of antithrombotic therapy with no antithrombotic therapy after hospitalization for 48 hours or longer for COVID-19. For Stage 1 of this study, participants will be randomized to either prophylactic anticoagulation or matching placebo for 30 days, and then followed for an additional 60 days after the completion of treatment (total duration of follow-up, 90 days).

The primary objective is to determine the most effective and safe antithrombotic strategy to prevent the composite outcome of symptomatic deep vein thrombosis, pulmonary embolism, other venous thromboembolism, ischemic stroke, myocardial infarction, other arterial thromboembolism, and all-cause mortality by 30 days following discharge from the hospital.

Biobanking of samples for future biomarker and mechanistic studies will be available for centers able to participate and collect samples from eligible participants. Samples will be collected at the time of enrollment and after the completion of 30 days of therapy

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1291
Inclusion Criteria
  • • Age ≥ 18 years

    • PCR-positive COVID-19 infection
    • Hospitalized for two or more days
Exclusion Criteria
  • Pre-existing indication for anticoagulation (e.g., pulmonary embolism or deep vein thrombosis; atrial fibrillation; mechanical cardiac valve)
  • Contraindication to antithrombotic therapy (e.g., known bleeding within the last 30 days requiring emergency room presentation or hospitalization; major surgery within 14 days; ischemic stroke, intracranial bleed or neurosurgery within 3 months.
  • Platelet count < 50,000/mcL
  • Hemoglobin <8 gm/dL
  • Renal insufficiency (eGFR < 30 mL/min/1.73 m2)
  • Pregnancy
  • Prison inmate
  • Life expectancy less than 90 days
  • Unwilling or unable to provide informed consent/unwilling or unable to complete the study protocol
  • Dual antiplatelet therapy that cannot be discontinued
  • Concomitant need for strong inducers/inhibitors of p-gp or CYP3A4

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ApixabanApixaban 2.5 MGDrug: Apixaban 2.5 MG Participants will be given study medication at the time of discharge from the hospital. Participants will take Apixaban 2.5 MG twice a day, once in the morning and once in the evening, for 30 days. Participants will be contacted (electronic or telephone) 2 days after starting the study medication and contact will continue up to day 90 after starting study treatment. Follow up will be through electronic and/or telephone contact depending on the participant's preference, compliance, and medication adherence. Participants will be queried for any clinically relevant endpoints, especially major bleeding or a need to seek healthcare attention for any reason. Follow-up will occur from the time of discharge and through the 30 day study period, with contacts 2 days, 10 days, 20 days, and 30 days after discharge. Two additional study contacts will take place 45 days and 90 days after discharge.
PlaceboPlaceboDrug: Placebo Participants will be given study medication at the time of discharge from the hospital. Participants will take the Placebo twice a day, once in the morning and once in the evening, for 30 days. Participants will be contacted (electronic or telephone) 2 days after starting the study medication and contact will continue up to day 90 after starting study treatment. Follow up will be through electronic and/or telephone contact depending on the participant's preference, compliance, and medication adherence. Participants will be queried for any clinically relevant endpoints, especially major bleeding or a need to seek healthcare attention for any reason. Follow-up will occur from the time of discharge and through the 30 day study period, with contacts 2 days, 10 days, 20 days, and 30 days after discharge. Two additional study contacts will take place 45 days and 90 days after discharge.
Primary Outcome Measures
NameTimeMethod
Composite Outcome of Symptomatic Deep Vein Thrombosis, Pulmonary Embolism, Other Venous Thromboembolism, Ischemic Stroke, Myocardial Infarction, Other Arterial Thromboembolism, and All-cause Mortality as Measured by Hospital Records.30 days after hospital discharge

Composite endpoint (CE) of venous and arterial thrombotic complications-including new, symptomatic proximal, or distal DVT of the upper or lower extremities, PE, and new thrombosis of other veins (including cerebral sinus and splanchnic veins), ischemic stroke, myocardial infarction, other arterial thromboembolism (e.g., mesenteric or acute limb ischemia), and all-cause mortality by day 30.

Secondary Outcome Measures
NameTimeMethod
New, Symptomatic VTE (Inclusive of DVT, PE, or Other Venous Thrombosis) for up to 30 Days After Randomization as Measured by Hospital Records.30 days after randomization (which occurred at time of hospital discharge)
New, Symptomatic ATE (Inclusive of Ischemic Stroke, MI, or Peripheral Arterial Thromboembolism) for up to 30 Days After Randomization as Measured by Hospital Records.30 days after randomization (which occurred at time of hospital discharge)
The Composite Outcome of All-cause Mortality and the EuroQoL Group 5-Dimension (EQ5D) Index Score.30 days after hospital discharge

Composite endpoint of mortality and EQ5D index at Day 30. All mortality events will be considered worse than any possible EQ5D response \[QOL\&M30\]. Death was designated as a score of 0. Scores range from 0 (where 0 is the value of a health state equivalent to dead) to 1 (the value of full health), with higher scores indicating higher health utility.

The Composite Outcome of Symptomatic Deep Vein Thrombosis, Pulmonary Embolism, Other Venous Thromboembolism, Ischemic Stroke, Myocardial Infarction, Other Arterial Thromboembolism, and All-cause Mortality as Measured by Hospital Records.90 days after hospital discharge
The Composite Outcome of All-cause Mortality and the EQ5D Index Score.90 days after hospital discharge

Composite endpoint of mortality and EQ5D index at Day 90. All mortality events will be considered worse than any possible EQ5D response. Death was designated as a score of 0. Scores range from 0 (where 0 is the value of a health state equivalent to dead) to 1 (the value of full health), with higher scores indicating higher health utility.

Trial Locations

Locations (121)

Kettering Medical Center

🇺🇸

Kettering, Ohio, United States

The Woodlands Center For Respiratory & Sleep Research

🇺🇸

The Woodlands, Texas, United States

CAMC Clinical Trials Center

🇺🇸

Charleston, West Virginia, United States

Ohio State University

🇺🇸

Columbus, Ohio, United States

University of Illinois at Chicago

🇺🇸

Chicago, Illinois, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

Cook County Health

🇺🇸

Chicago, Illinois, United States

Boston University

🇺🇸

Boston, Massachusetts, United States

Truman Medical Center

🇺🇸

Kansas City, Missouri, United States

Indiana University Health Methodist Hospital

🇺🇸

Indianapolis, Indiana, United States

University of Texas- Houston, LBJ Hospital

🇺🇸

Houston, Texas, United States

UTHouston

🇺🇸

Houston, Texas, United States

UT Houston MHH-SW

🇺🇸

Houston, Texas, United States

St. Anthony North Health Campus

🇺🇸

Westminster, Colorado, United States

Mount Sinai Medical Center

🇺🇸

Miami Beach, Florida, United States

Medical College of Georgia/Augusta University

🇺🇸

Augusta, Georgia, United States

Torrance Medical Center

🇺🇸

Torrance, California, United States

Central Arkansas Veterans Health Care System

🇺🇸

Little Rock, Arkansas, United States

New Ananda Medical and Urgent Care, Inc.

🇺🇸

S. El Monte, California, United States

Lifebridge (Sinai Hospital of Baltimore)

🇺🇸

Baltimore, Maryland, United States

Snake River Research, PLLC

🇺🇸

Idaho Falls, Idaho, United States

Mercy Hospital Buffalo

🇺🇸

Buffalo, New York, United States

Lutheran Medical Group

🇺🇸

Fort Wayne, Indiana, United States

Renown Health

🇺🇸

Reno, Nevada, United States

New York University Langone Health

🇺🇸

New York, New York, United States

Capital Health System, Inc.

🇺🇸

Trenton, New Jersey, United States

Emory University

🇺🇸

Atlanta, Georgia, United States

Baystate Medical center

🇺🇸

Springfield, Massachusetts, United States

Indiana University Health Bloomington Hospital

🇺🇸

Bloomington, Indiana, United States

NYU Langone Hospital-Brooklyn

🇺🇸

Brooklyn, New York, United States

St Louis University

🇺🇸

Saint Louis, Missouri, United States

Adventist HealthCare Shady Grove Medical Center

🇺🇸

Rockville, Maryland, United States

Newark Beth Israel Medical Center

🇺🇸

Newark, New Jersey, United States

Hope Tower at Jersey Shore University Medical Center

🇺🇸

Neptune, New Jersey, United States

The University of Chicago Medicine

🇺🇸

Chicago, Illinois, United States

East Carolina University/Vidant Health

🇺🇸

Greenville, North Carolina, United States

Wake Med Hospital

🇺🇸

Raleigh, North Carolina, United States

Pen Bay Medical Center

🇺🇸

Rockport, Maine, United States

McLaren Macomb

🇺🇸

Mount Clemens, Michigan, United States

Barnes-Jewish Hospital

🇺🇸

Saint Louis, Missouri, United States

CHI St Elizabeth Hospital

🇺🇸

Lincoln, Nebraska, United States

Summa Health

🇺🇸

Akron, Ohio, United States

Maine Medical Center/Maine Medical Partners Adult Hospital Medicine

🇺🇸

Portland, Maine, United States

Buffalo General Medical Center

🇺🇸

Buffalo, New York, United States

Franciscan Health Michigan City

🇺🇸

Michigan City, Indiana, United States

Dartmouth Hichcock Medical Center

🇺🇸

Lebanon, New Hampshire, United States

Baylor Scott and White-Temple

🇺🇸

Temple, Texas, United States

UT Rio Grande Valley

🇺🇸

Weslaco, Texas, United States

University of Texas Southwestern Medical Center

🇺🇸

Dallas, Texas, United States

MidMichigan Medical Center

🇺🇸

Midland, Michigan, United States

Tower Health Medical Group

🇺🇸

West Reading, Pennsylvania, United States

Texas Health Frisco

🇺🇸

Plano, Texas, United States

Christus St. Vincent Regional Medical Center

🇺🇸

Santa Fe, New Mexico, United States

Westchester Medical Center

🇺🇸

Valhalla, New York, United States

Monument Health Clinical Research

🇺🇸

Rapid City, South Dakota, United States

Ascension St. John Tulsa

🇺🇸

Tulsa, Oklahoma, United States

Conemaugh Memorial Medical Center

🇺🇸

Johnstown, Pennsylvania, United States

Stony Brook University Hospital

🇺🇸

Stony Brook, New York, United States

University of Pittsburgh

🇺🇸

Pittsburgh, Pennsylvania, United States

CHRISTUS Trinity Clinic Pulmonary Medicine

🇺🇸

Tyler, Texas, United States

St. Luke's University Health Network

🇺🇸

Easton, Pennsylvania, United States

Ascension St. John Bartlesville

🇺🇸

Tulsa, Oklahoma, United States

Erlanger Health System

🇺🇸

Chattanooga, Tennessee, United States

Baylor Scott and White-Round Rock

🇺🇸

Round Rock, Texas, United States

MultiCare Institute for Research & Innovation

🇺🇸

Puyallup, Washington, United States

Texas Health Harris Methodist

🇺🇸

Fort Worth, Texas, United States

Christus St. Elizabeth Hospital

🇺🇸

Beaumont, Texas, United States

Virginia Mason Medical Center

🇺🇸

Seattle, Washington, United States

West Virginia University Hospital

🇺🇸

Morgantown, West Virginia, United States

University of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

Minneapolis VA Health Care System

🇺🇸

Minneapolis, Minnesota, United States

Duke Medical Center

🇺🇸

Durham, North Carolina, United States

UCSF at Zuckerberg San Francisco General Hospital

🇺🇸

San Francisco, California, United States

Vanderbilt University Medical Center

🇺🇸

Nashville, Tennessee, United States

The Miriam Hospital

🇺🇸

Providence, Rhode Island, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

Mercury Street Medical Group

🇺🇸

Butte, Montana, United States

Valleywise Health Medical Center

🇺🇸

Phoenix, Arizona, United States

Dignity Health-St Josephs

🇺🇸

Phoenix, Arizona, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Centura Health Porter Adventist Hospital

🇺🇸

Denver, Colorado, United States

Oregon Health and Science University

🇺🇸

Portland, Oregon, United States

Blood Center of Wisconsin

🇺🇸

Milwaukee, Wisconsin, United States

James A. Haley Veteran's Hospital

🇺🇸

Tampa, Florida, United States

Wake Forest Baptist Medical Center

🇺🇸

Winston-Salem, North Carolina, United States

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

Stanford University School of Medicine

🇺🇸

Palo Alto, California, United States

Mazur and Statner MD PC

🇺🇸

Thousand Oaks, California, United States

Saint Anthony Hospital

🇺🇸

Lakewood, Colorado, United States

Baycare Hospital

🇺🇸

Clearwater, Florida, United States

Florida Heart Center

🇺🇸

Fort Pierce, Florida, United States

BayCare Hospital- Winter Haven

🇺🇸

Winter Haven, Florida, United States

Tallahassee Memorial HealthCare

🇺🇸

Tallahassee, Florida, United States

Savannah Health Services, LLC DBA Memorial Health University Medical Center

🇺🇸

Savannah, Georgia, United States

Loyola University Medical Center

🇺🇸

Maywood, Illinois, United States

OSF Little Company of Mary

🇺🇸

Evergreen Park, Illinois, United States

Reid Physician Associates

🇺🇸

Richmond, Indiana, United States

Willis-Knighton Physician Network/Tri-State Medical Clinic

🇺🇸

Shreveport, Louisiana, United States

Anne Arundel Medical Center

🇺🇸

Annapolis, Maryland, United States

Lahey Hospital and Medical Center

🇺🇸

Burlington, Massachusetts, United States

Bay Regional Medical Center d/b/a/ McLaren Bay Region

🇺🇸

Bay City, Michigan, United States

Western Michigan University

🇺🇸

Kalamazoo, Michigan, United States

Coney Island Hospital

🇺🇸

Brooklyn, New York, United States

AtlantiCare Regional Medical Center

🇺🇸

Atlantic City, New Jersey, United States

Jamaica Hospital Medical Center

🇺🇸

Jamaica, New York, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Temple University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

Baylor Scott and White Medical Center- College Station

🇺🇸

College Station, Texas, United States

UT Health East Texas (Tyler)

🇺🇸

Tyler, Texas, United States

UW Medicine Valley Medical Center

🇺🇸

Renton, Washington, United States

The University of Texas Health Science Center at Tyler

🇺🇸

Tyler, Texas, United States

University of Florida

🇺🇸

Gainesville, Florida, United States

Queens Medical Center

🇺🇸

Honolulu, Hawaii, United States

Hawaii Pacific Health

🇺🇸

Honolulu, Hawaii, United States

University Medical Center New Orleans

🇺🇸

New Orleans, Louisiana, United States

Ochsner Clinic Foundation-Baton Rouge

🇺🇸

New Orleans, Louisiana, United States

Ochsner Clinic Foundation

🇺🇸

New Orleans, Louisiana, United States

University of North Carolina at Chapel Hill

🇺🇸

Chapel Hill, North Carolina, United States

Baptist Health Lexington

🇺🇸

Lexington, Kentucky, United States

Montefiore Medical Center

🇺🇸

Bronx, New York, United States

Rhode Island Hospital

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath